Back to Search
RICARDO MORANT, D.M.D.
D.M.D.
Endodontics
NPI: 1518306638Individual
Specialties, Licenses & Credentials
EndodonticsPrimary
Dentist — Endodontics
Code: 1223E0200X
008924(CT)
Research & Publications (20)
Chemoprevention of breast and prostate cancers: where do we stand?
PMID 18790958·Ann Oncol·2008
8-other
Quality of analgesic treatment in patients with advanced prostate cancer: do we do a better job now? The Swiss Group for Clinical Cancer Research (SAKK) experience.
PMID 17909864·Support Care Cancer·2008
4-observational
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.
PMID 18040273·Br J Cancer·2007
3-trial
An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer.
PMID 17596743·Onkologie·2007
3-trial
Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment.
PMID 16507565·Ann Oncol·2006
4-observational
Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients.
PMID 16934972·Eur J Cancer·2006
8-other
Occupational pesticide intoxications among farmers in Bolivia: a cross-sectional study.
PMID 16630337·Environ Health·2006
8-other
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma.
PMID 16052341·Cancer Chemother Pharmacol·2006
3-trial
Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer.
PMID 15998587·Breast·2006
3-trial
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study.
PMID 15756271·Br J Cancer·2005
3-trial
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer.
PMID 15955899·J Clin Oncol·2005
3-trial
Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myeloma.
PMID 16225652·Br J Haematol·2005
4-observational
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study.
PMID 15817597·Ann Oncol·2005
3-trial
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial.
PMID 15054447·Br J Cancer·2004
3-trial
Chemotherapy-induced nausea and vomiting in routine practice: a European perspective.
PMID 15278682·Support Care Cancer·2004
4-observational
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial.
PMID 15111343·Ann Oncol·2004
3-trial
Prostate specific antigen doubling time as auxiliary end point in hormone refractory prostatic carcinoma.
PMID 12507540·Eur Urol·2003
8-other
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial.
PMID 12506172·J Clin Oncol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1358 BOSTON POST RD, SUITE 2
OLD SAYBROOK, CT 06475 - Phone
- (860) 388-3522
Quick Facts
- NPI
- 1518306638
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile